Vollständiger Abstract
Worum geht es in dieser Arbeit?
Objectives: Although maintenance dialysis prevents death from uremia, mortality among patients with end-stage kidney disease-ESKD remains high. Hence, this study aims to detect the demographic, clinical, and laboratory parameters that contribute to long-term survival on hemodialysis-HD. Material and Methods: We conducted a retrospective case-control comparative study based on a single-center experience involving patients on regular HD aged 18 years and older at ASSEEB RDC, the second-largest dialysis center in Oman (serving over 200 patients). The study compares the demographic, laboratory, and clinical data of patients with short-term survival on HD (10 years). Both groups consisted of an equal number of patients ( n =34 each). Results: Most patients with HD are middle-aged (24-64 years). In the long-term survival group, the gender distribution was equal, whereas males were more prominent than females in the short-term survival group (67% versus 32%). Diabetic nephropathy was the primary cause of ESKD in our study population (88% in both groups). Hypertension-HTN and ischemic heart disease-IHD were more prevalent in the short-term survival group than in the long-term survival group (82% and 23% versus 29% and 6%, respectively, p
Bibliografischer Nachweis
Publikationsdaten
- Autor:innen
- Ahmed Atris, Issa Al Salmi, Munira JM Alamrani, Ghada AI Al Balushi, Nahid H Alyahmadi, Michael Mamdouh Soliaman, Hamed Ali Said Ahmad AlShahri
- Quelle
- World Advances in Renal Medicine
- Publikation
- 2026-01-01
- Band / Ausgabe
- Nicht angegeben
- Seiten
- Nicht angegeben
- ISSN / ISBN
- 3069-146X
- Zitationen
- 0 laut Crossref
- Referenzen
- 0 hinterlegt
Zitieren
Zitierfähiger Nachweis
Ahmed Atris, Issa Al Salmi, Munira JM Alamrani, Ghada AI Al Balushi, Nahid H Alyahmadi, Michael Mamdouh Soliaman, Hamed Ali Said Ahmad AlShahri (2026). Identifying key prognostic indicators for extended hemodialysis survival: A comprehensive analysis of clinical, laboratory, and demographic factors. World Advances in Renal Medicine. https://doi.org/10.25259/warm_12_2026